Skip to main content
Premium Trial:

Request an Annual Quote

BGI, Leiden to Use FlexGen Target Enrichment in Dutch Genome Project

Premium

FlexGen of the Netherlands said last week that China's BGI and Leiden University Medical Center will use its target enrichment technology to validate variants for the Genome of the Netherlands, or GoNL, project.

The researchers will use the platform to validate a set of variants found in trio samples from the GoNL project. Launched in 2010, the project aims to sequence the genomes of about 250 Dutch parent-child trios. The sequencing is performed at BGI's Hong Kong facility.

FlexGen, located in the Leiden Bio Science Park, was founded in 2004 as a spinoff from Leiden University Medical Center and Dutch Space. The company offers FleXelect custom target enrichment kits.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.